CSIMarket
 


American Bio Medica Corporation  (ABMC)
Other Ticker:  
 

American Bio Medica's Working Capital Ratio

ABMC's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


Current Liabilities decreased faster than American Bio Medica's Current Assets, this led to improvement in American Bio Medica's Working Capital Ratio to 0.59, Working Capital Ratio remained below American Bio Medica Corporation average.

Within Major Pharmaceutical Preparations industry 523 other companies have achieved higher Working Capital Ratio than American Bio Medica in first quarter 2023. While Working Capital Ratio total ranking has improved so far during the I Quarter 2023 to 4476, from total ranking in the forth quarter 2022 at 4644.

Explain Working Capital Ratio
How much in Current Assets ABMC´s has?
What is the value of ABMC´s Current Liabilities?


ABMC Working Capital Ratio (Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Current Liabilities Change -61.09 % 27.55 % 6.83 % -4.67 % -9.35 %
Y / Y Current Assets Change -36.51 % -42.61 % -58.36 % -22.14 % -0.95 %
Working Capital Ratio MRQ 0.59 0.21 0.21 0.25 0.36
ABMC's Total Ranking # 4476 # 4644 # 4767 # 4835 # 4523
Seq. Current Liabilities Change -68.99 % 12.84 % 7.77 % 3.17 % 1.66 %
Seq. Current Assets Change -14.3 % 14.78 % -9.7 % -28.52 % -22.54 %



Working Capital Ratio first quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 524
Healthcare Sector # 1054
Overall Market # 4476


Working Capital Ratio Statistics
High Average Low
1.79 0.98 0.21
(Dec 31 2011)   (Sep 30 2022)




Financial Statements
American Bio Medica's Current Liabilities $ 1 Millions Visit ABMC's Balance sheet
American Bio Medica's Current Assets $ 1 Millions Visit ABMC's Balance sheet
Source of ABMC's Sales Visit ABMC's Sales by Geography


Cumulative American Bio Medica's Working Capital Ratio

ABMC's Working Capital Ratio for the trailling 12 Months

ABMC Working Capital Ratio

(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
Y / Y Current Liabilities TTM Growth -61.09 % 27.55 % 6.83 % -4.67 % -9.35 %
Y / Y Current Assets TTM Growth -36.51 % -42.61 % -58.36 % -22.14 % -0.95 %
Working Capital Ratio TTM 0.26 0.25 0.32 0.41 0.42
Total Ranking TTM # 4427 # 4054 # 3901 # 4269 # 4895
Seq. Current Liabilities TTM Growth -68.99 % 12.84 % 7.77 % 3.17 % 1.66 %
Seq. Current Assets TTM Growth -14.3 % 14.78 % -9.7 % -28.52 % -22.54 %


On the trailing twelve months basis Current Liabilities decreased faster than American Bio Medica's average Current Assets, this led to increase in in American Bio Medica's Working Capital Ratio to 0.26, Working Capital Ratio remained below ABMC average.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 554 other companies have achieved higher Working Capital Ratio than American Bio Medica. While Working Capital Ratio total ranking has deteriorated compared to the previous twelve months ending in the forth quarter 2022 from 4054 to 4427.

Explain Working Capital Ratio
How much in Current Assets ABMC´s has?
What is the value of ABMC´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 555
Healthcare Sector # 1139
Within the Market # 4427


trailing twelve months Working Capital Ratio Statistics
High Average Low
1.56 0.94 0.25
(Sep 30 2016)   (Dec 31 2022)




Companies with similar Working Capital Ratio in the quarter ending Mar 31 2023, within Major Pharmaceutical Preparations Industry Working Capital RatioMar 31 2023 MRQ Current AssetsMar 31 2023 MRQ Current Liabilities
Organon and Co   1.61 $ 3,780.000  Millions$ 2,346.000  Millions
Cv Sciences Inc   1.60 $ 10.000  Millions$ 6.253  Millions
Viatris Inc   1.58 $ 9,630.300  Millions$ 6,108.100  Millions
Fortress Biotech Inc   1.56 $ 202.381  Millions$ 129.473  Millions
Biolinerx Ltd   1.53 $ 47.183  Millions$ 30.852  Millions
Avid Bioservices Inc   1.53 $ 112.451  Millions$ 73.709  Millions
Oncorus Inc   1.50 $ 46.670  Millions$ 31.108  Millions
Clene Inc   1.47 $ 24.822  Millions$ 16.876  Millions
Assertio Holdings inc   1.46 $ 137.849  Millions$ 94.545  Millions
Sanofi  1.45 $ 23,242.240  Millions$ 16,068.640  Millions
Merck and Co Inc   1.44 $ 33,402.000  Millions$ 23,131.000  Millions
Akebia Therapeutics Inc   1.44 $ 120.719  Millions$ 83.704  Millions
Pfizer Inc  1.44 $ 50,078.000  Millions$ 34,812.000  Millions
Kazia Therapeutics Limited  1.42 $ 10.772  Millions$ 7.565  Millions
Bristol myers Squibb Company  1.42 $ 27,086.000  Millions$ 19,085.000  Millions
Johnson and Johnson  1.41 $ 64,388.000  Millions$ 45,589.000  Millions
Pieris Pharmaceuticals Inc   1.41 $ 60.505  Millions$ 42.875  Millions
Cytomx Therapeutics Inc   1.40 $ 212.277  Millions$ 151.262  Millions
Ptc Therapeutics inc   1.39 $ 613.392  Millions$ 441.634  Millions
Avadel Pharmaceuticals Plc  1.38 $ 109.470  Millions$ 79.361  Millions
First Wave Biopharma Inc   1.34 $ 3.530  Millions$ 2.625  Millions
Theratechnologies Inc   1.34 $ 63.297  Millions$ 47.294  Millions
Scynexis Inc   1.32 $ 59.767  Millions$ 45.348  Millions
Therapeuticsmd Inc   1.28 $ 24.735  Millions$ 19.336  Millions
Cti Biopharma Corp   1.27 $ 86.453  Millions$ 68.226  Millions
Ibio inc   1.22 $ 27.093  Millions$ 22.276  Millions
Dar Bioscience Inc   1.21 $ 29.512  Millions$ 24.338  Millions
Supernus Pharmaceuticals inc   1.21 $ 883.340  Millions$ 731.545  Millions
Collegium Pharmaceutical Inc   1.21 $ 498.300  Millions$ 412.702  Millions
Eterna Therapeutics Inc   1.21 $ 6.515  Millions$ 5.406  Millions

Date modified: 2023-06-13T06:39:55+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com